Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cécile Goujard

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Clinical Pharmacokinetics|September 24, 2005
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavirClotilde Le Tiec, Aurélie Barrail, Cécile Goujard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 14, 2003
Liquid chromatography-tandem mass spectrometry assays for intracellular deoxyribonucleotide triphosphate competitors of nucleoside antiretroviralsGaëlle Henneré, François Becher, Alain Pruvost, et al.
Cytokine & Growth Factor Reviews|March 21, 2018
Interferon-associated therapies toward HIV control: The back and forthNicolas Noël, Béatrice Jacquelin, Nicolas Huot, et al.
European Journal of Clinical Pharmacology|August 19, 2007
Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAARTXavière Panhard, Mayeule Legrand, Anne-Marie Taburet, et al.
AIDS (London, England)|November 21, 2002
Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohortLoïc Desquilbet, Christiane Deveau, Cécile Goujard, et al.
Fundamental & Clinical Pharmacology|May 25, 2005
Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapyKarl Brendel, Mayeule Legrand, Anne-Marie Taburet, et al.
The Journal of Rheumatology|July 5, 2005
Efficacy of rituximab in refractory polymyositisOlivier Lambotte, Rami Kotb, Gwenola Maigne, et al.
Journal of Mass Spectrometry : JMS|January 12, 2005
Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matricesSéverine Compain, Dimitri Schlemmer, Mikaël Levi, et al.
BMC Infectious Diseases|September 3, 2014
Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patientsMartin Duracinsky, Pascale Leclercq, Susan Herrmann, et al.
Rapid Communications in Mass Spectrometry : RCM|March 1, 2002
Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometryFrançois Becher, Alain Pruvost, Cécile Goujard, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Clinical Pharmacokinetics|September 24, 2005
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavirClotilde Le Tiec, Aurélie Barrail, Cécile Goujard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 14, 2003
Liquid chromatography-tandem mass spectrometry assays for intracellular deoxyribonucleotide triphosphate competitors of nucleoside antiretroviralsGaëlle Henneré, François Becher, Alain Pruvost, et al.
Cytokine & Growth Factor Reviews|March 21, 2018
Interferon-associated therapies toward HIV control: The back and forthNicolas Noël, Béatrice Jacquelin, Nicolas Huot, et al.
European Journal of Clinical Pharmacology|August 19, 2007
Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAARTXavière Panhard, Mayeule Legrand, Anne-Marie Taburet, et al.
AIDS (London, England)|November 21, 2002
Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohortLoïc Desquilbet, Christiane Deveau, Cécile Goujard, et al.
Fundamental & Clinical Pharmacology|May 25, 2005
Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapyKarl Brendel, Mayeule Legrand, Anne-Marie Taburet, et al.
The Journal of Rheumatology|July 5, 2005
Efficacy of rituximab in refractory polymyositisOlivier Lambotte, Rami Kotb, Gwenola Maigne, et al.
Journal of Mass Spectrometry : JMS|January 12, 2005
Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matricesSéverine Compain, Dimitri Schlemmer, Mikaël Levi, et al.
BMC Infectious Diseases|September 3, 2014
Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patientsMartin Duracinsky, Pascale Leclercq, Susan Herrmann, et al.
Rapid Communications in Mass Spectrometry : RCM|March 1, 2002
Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometryFrançois Becher, Alain Pruvost, Cécile Goujard, et al.
Pageof 18